Conrad Wong - Publications

Behavioral Sciences and Psychiatry University of Kentucky, Lexington, KY 

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Holtyn AF, Jarvis BP, Subramaniam S, Wong CJ, Fingerhood M, Bigelow GE, Silverman K. An intensive assessment of alcohol use and emergency department utilization in homeless alcohol-dependent adults. Drug and Alcohol Dependence. 178: 28-31. PMID 28624603 DOI: 10.1016/j.drugalcdep.2017.04.025  0.84
2016 Holtyn AF, Washington WD, Knealing TW, Wong CJ, Kolodner K, Silverman K. Behavioral factors predicting response to employment-based reinforcement of cocaine abstinence in methadone patients. Translational Issues in Psychological Science. 2: 192-202. PMID 27777965 DOI: 10.1037/tps0000056  0.84
2016 Rorick-Kehn LM, Ciccocioppo R, Wong CJ, Witkin JM, Martinez-Grau MA, Stopponi S, Adams BL, Katner JS, Perry KW, Toledo MA, Diaz N, Lafuente C, Jiménez A, Benito A, Pedregal C, et al. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models. Alcoholism, Clinical and Experimental Research. PMID 27084498 DOI: 10.1111/acer.13052  0.84
2014 Rorick-Kehn LM, Witcher JW, Lowe SL, Gonzales CR, Weller MA, Bell RL, Hart JC, Need AB, McKinzie JH, Statnick MA, Suico JG, McKinzie DL, Tauscher-Wisniewski S, Mitch CH, Stoltz RR, ... Wong CJ, et al. Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25637376 DOI: 10.1093/ijnp/pyu036  0.84
2014 Aklin WM, Wong CJ, Hampton J, Svikis DS, Stitzer ML, Bigelow GE, Silverman K. A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention. Journal of Substance Abuse Treatment. 47: 329-38. PMID 25124257 DOI: 10.1016/j.jsat.2014.06.013  0.84
2014 Lowe SL, Wong CJ, Witcher J, Gonzales CR, Dickinson GL, Bell RL, Rorick-Kehn L, Weller M, Stoltz RR, Royalty J, Tauscher-Wisniewski S. Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects. Journal of Clinical Pharmacology. 54: 968-78. PMID 24619932 DOI: 10.1002/jcph.286  0.84
2014 Dunn KE, Fingerhood M, Wong CJ, Svikis DS, Nuzzo P, Silverman K. Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients. Experimental and Clinical Psychopharmacology. 22: 75-85. PMID 24490712 DOI: 10.1037/a0034863  0.84
2014 Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, et al. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Neuropharmacology. 77: 131-44. PMID 24071566 DOI: 10.1016/j.neuropharm.2013.09.021  0.84
2014 Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y, Fijal BA, Ouyang H, Dharia S, Sundseth SS, Schuh KJ, Kinon BJ. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence. Alcoholism, Clinical and Experimental Research. 38: 511-20. PMID 24010675 DOI: 10.1111/acer.12257  0.84
2013 Koffarnus MN, Wong CJ, Fingerhood M, Svikis DS, Bigelow GE, Silverman K. Monetary incentives to reinforce engagement and achievement in a job-skills training program for homeless, unemployed adults. Journal of Applied Behavior Analysis. 46: 582-91. PMID 24114221 DOI: 10.1002/jaba.60  0.84
2013 Walsh SL, Middleton LS, Wong CJ, Nuzzo PA, Campbell CL, Rush CR, Lofwall MR. Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial. Drug and Alcohol Dependence. 130: 150-7. PMID 23200303 DOI: 10.1016/j.drugalcdep.2012.10.024  0.84
2012 Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, ... ... Wong CJ, et al. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug and Alcohol Dependence. 120: 55-64. PMID 21802222 DOI: 10.1016/j.drugalcdep.2011.06.024  0.84
2011 Koffarnus MN, Wong CJ, Diemer K, Needham M, Hampton J, Fingerhood M, Svikis DS, Bigelow GE, Silverman K. A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults. Alcohol and Alcoholism (Oxford, Oxfordshire). 46: 561-9. PMID 21622676 DOI: 10.1093/alcalc/agr057  0.84
2009 DeFulio A, Donlin WD, Wong CJ, Silverman K. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial. Addiction (Abingdon, England). 104: 1530-8. PMID 19686522 DOI: 10.1111/j.1360-0443.2009.02657.x  0.84
2008 Oser C, Havens J, Staton-Tindall M, Wong C, Leukefeld C, Prendergast M. HIV Sexual Risk Behaviors among Ketamine and Non-Ketamine Using Criminal Offenders Prior to Prison Entry. Addiction Research & Theory. 16: 289-302. PMID 19287506 DOI: 10.1080/16066350801983723  0.84
2008 Donlin WD, Knealing TW, Needham M, Wong CJ, Silverman K. Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients. Journal of Applied Behavior Analysis. 41: 499-516. PMID 19192855 DOI: 10.1901/jaba.2008.41-499  0.84
2008 Knealing TW, Roebuck MC, Wong CJ, Silverman K. Economic cost of the therapeutic workplace intervention added to methadone maintenance. Journal of Substance Abuse Treatment. 34: 326-32. PMID 17614239 DOI: 10.1016/j.jsat.2007.04.013  0.84
2007 Silverman K, Wong CJ, Needham M, Diemer KN, Knealing T, Crone-Todd D, Fingerhood M, Nuzzo P, Kolodner K. A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users. Journal of Applied Behavior Analysis. 40: 387-410. PMID 17970256 DOI: 10.1901/jaba.2007.40-387  0.84
2007 Carpenedo CM, Needham M, Knealing TW, Kolodner K, Fingerhood M, Wong CJ, Silverman K. Professional demeanor of chronically unemployed cocaine-dependent methadone patients in a therapeutic workplace. Substance Use & Misuse. 42: 1141-59. PMID 17668330 DOI: 10.1080/10826080701410089  0.84
2007 Wong CJ, Silverman K. Establishing and maintaining job skills and professional behaviors in chronically unemployed drug abusers. Substance Use & Misuse. 42: 1127-40. PMID 17668329 DOI: 10.1080/10826080701407952  0.84
2006 Knealing TW, Wong CJ, Diemer KN, Hampton J, Silverman K. A randomized controlled trial of the therapeutic workplace for community methadone patients: a partial failure to engage. Experimental and Clinical Psychopharmacology. 14: 350-60. PMID 16893278 DOI: 10.1037/1064-1297.14.3.350  0.84
2005 Jones HE, Wong CJ, Tuten M, Stitzer ML. Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug and Alcohol Dependence. 79: 119-28. PMID 16002021 DOI: 10.1016/j.drugalcdep.2005.01.006  0.84
2005 Silverman K, Wong CJ, Grabinski MJ, Hampton J, Sylvest CE, Dillon EM, Wentland RD. A web-based therapeutic workplace for the treatment of drug addiction and chronic unemployment. Behavior Modification. 29: 417-63. PMID 15657415 DOI: 10.1177/0145445504272600  0.84
2004 Dillon EM, Wong CJ, Sylvest CE, Crone-Todd DE, Silverman K. Computer-based typing and keypad skills raining outcomes of unemployed injection drug users in a therapeutic workplace. Substance Use & Misuse. 39: 2325-53. PMID 15603007 DOI: 10.1081/JA-200034620  0.84
2004 Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE. Evaluation of an injection depot formulation of buprenorphine: Placebo comparison Addiction. 99: 1439-1449. PMID 15500597 DOI: 10.1111/j.1360-0443.2004.00834.x  0.84
2004 Wong CJ, Anthony S, Sigmon SC, Mongeon JA, Badger GJ, Higgins ST. Examining interrelationships between abstinence and coping self-efficacy in cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 12: 190-9. PMID 15301636 DOI: 10.1037/1064-1297.12.3.190  0.84
2004 Wong CJ, Dillon EM, Sylvest C, Silverman K. Evaluation of a modified contingency management intervention for consistent attendance in therapeutic workplace participants. Drug and Alcohol Dependence. 74: 319-23. PMID 15194210 DOI: 10.1016/j.drugalcdep.2003.12.013  0.84
2004 Wong CJ, Dillon EM, Sylvest CE, Silverman K. Contingency management of reliable attendance of chronically unemployed substance abusers in a therapeutic workplace. Experimental and Clinical Psychopharmacology. 12: 39-46. PMID 14769098 DOI: 10.1037/1064-1297.12.1.39  0.84
2003 Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, Dantona RL, Anthony S. Community reinforcement therapy for cocaine-dependent outpatients. Archives of General Psychiatry. 60: 1043-52. PMID 14557150 DOI: 10.1001/archpsyc.60.9.1043  0.84
2003 Wong CJ, Sheppard JM, Dallery J, Bedient G, Robles E, Svikis D, Silverman K. Effects of reinforcer magnitude on data-entry productivity in chronically unemployed drug abusers participating in a Therapeutic Workplace. Experimental and Clinical Psychopharmacology. 11: 46-55. PMID 12622343 DOI: 10.1037//1064-1297.11.1.46  0.84
2002 Wong CJ, Badger GJ, Sigmon SC, Higgins ST. Examining possible gender differences among cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 10: 316-23. PMID 12233993 DOI: 10.1037//1064-1297.10.3.316  0.84
2002 Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Experimental and Clinical Psychopharmacology. 10: 228-40. PMID 12233983 DOI: 10.1037//1064-1297.10.3.228  0.84
Show low-probability matches.